U.S. Organ Donation System Needs 'Disruptive Innovation'

This article originally appeared here.
Share this content:
U.S. Organ Donation System Needs 'Disruptive Innovation'
U.S. Organ Donation System Needs 'Disruptive Innovation'

TUESDAY, June 2, 2015 (HealthDay News) -- Many state policies meant to increase organ donations and transplant rates have had almost no impact, according to new research published online June 1 in JAMA Internal Medicine.

The shortage of organs available for transplant is a major public health problem in the United States, according to study author Erika Martin, Ph.D., M.P.H., of the Rockefeller College of Public Affairs & Policy at the University at Albany, State University of New York, and her colleagues. Between 1988 and 2010, the number of states with at least one of six major measures designed to boost the organ supply increased from seven to 50, the team reported. But their review of national data revealed that five of these approaches have not increased donation rates or numbers of transplants. These policies include first-person consent laws, donor registries, public education, paid leave, and tax incentives.

In the study, only revenue policies -- where people can contribute to a state fund to promote organ donation -- have made a difference. This type of measure was associated with a 5.3 percent increase in the number of transplants, which works out to an average of 15 additional transplants per state a year. Revenue policies were also associated with a 4.9 percent increase in the number of deceased donors per capita and an 8.0 percent increase in the number of transplants of organs from deceased donors. This works out to an additional 6.5 deceased donors and eight transplants from deceased donors per state a year, the researchers found.

Sally Satel, M.D., of the Yale University School of Medicine in New Haven, Conn., and colleagues said they believe it's time for "disruptive innovation" in an editorial that accompanied the study. "By this concept, we mean compensating donors, not simply seeking to soften the financial ramification of donation. It is time to test incentives, to reward people who are willing to save the life of a stranger through donation," they suggested.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »